Hormonal replacement therapy and ovarian cancer

References

• Andersen Hudrup Y, Obel BO, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 2000; 79: 194–201.
   Google Scholar
• Backe B, Hunskaar S. Increased acceptance of HRT and improved level of information: a change in Norwegian women’s opinion form 1990–97. Acta Obstet Gynecol Scand 2001; 80: 623–7.
   Google Scholar
• Ylikorkala O. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS was no revolution. Acta Obstet Gynecol Scand 2000; 79: 1029–36.
   Google Scholar
• Polo-Kantola P Erkkola R. Alzheimer’s disease and estrogen replacement therapy – where are we now? Acta Obstet Gynecol Scand 2001; 80: 679–82.
   Google Scholar
• Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 2001; 285: 1460–5.
   Google Scholar
• Genazzani AR, Gadducci A, Gambacciani M. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. Maturitas 2001; 40: 117–30.
   Google Scholar
• Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol 1998; 49: 695–707.
   Google Scholar
• Fathalla MF. Incessant ovulation – a factor in ovarian neoplasia? Lancet 1971; ii: 163.
   Google Scholar
• Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975; 123: 772–4.
   Google Scholar
• Ylikorkala O. Tubal ligation reduces the risk of ovarian cancer. Acta Obstet Gynecol Scand 2001; 80: 875–7.
   Google Scholar
• Whittemore AS, Harris R, Itnyre J and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–203.
   Google Scholar
• Negri E, Tzonou A, Beral V, Lagiou P, Trichopoulous D, Parazzini F et al. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies. Int J Cancer 1999; 80: 848–51.
   Google Scholar
• Garg PP, Kerlikowske K, Subak L, Grady D. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998; 92: 472–9.
   Google Scholar
• Coughlin SS, Giustozzi A, Smith SJ, Lee NC. A metaanalysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol 2000; 53: 367–5.
   Google Scholar
• Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy – long-term follow-up of a Swedish cohort. Int J Cancer 1996; 67: 327–32.
   Google Scholar
• Pukkala E, Tulenheimo-Silfvast A, Leminen A. Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994–97. Cancer Causes Control 2001; 12: 111–5.
   Google Scholar
• Risch HA. Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol 1996; 63: 254–7.
   Google Scholar
• Hempling RE, Wong C, Piver S, Natarajan N, Mettlin CJ. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Obstet Gynecol 1997; 89: 1012–6.
   Google Scholar
• Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, Comstock GW. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995; 274: 1926–30.
   Google Scholar
• Chien C-H, Wang F-F, Hamilton HH. Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol Cell Endocrinol 1994; 99: 11–9.
   Google Scholar
• Rodriguez GC, Walmer DK, Cline M et al. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Invest 1998; 5: 271–6.
   Google Scholar
• Riman T, Dickman PW, Nilsson S et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002; 94: 497–504.
   Google Scholar
• Guidozzi F, Daponte A. Estrogen replacement therapy for ovarian carcinoma survivors. A randomized controlled trial. Cancer 1999; 86: 1013–8.
   Google Scholar